C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective
出版年份 2022 全文链接
标题
C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-06-09
DOI
10.1111/dom.14785
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The impact of low dose gliclazide on the incretin effect and indices of beta cell function
- (2021) Ruth L M Cordiner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia
- (2021) Rose A. Gubitosi-Klug et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of incretins on insulin function and glucose homeostasis
- (2021) Jens Juul Holst et al. ENDOCRINOLOGY
- Early impairment of insulin sensitivity, β-cell responsiveness, and insulin clearance in youth with Stage 1 type 1 diabetes
- (2021) Alfonso Galderisi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?
- (2021) Claire L. Meek et al. DIABETES CARE
- Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes
- (2021) Angus G. Jones et al. DIABETES CARE
- The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2021) Richard I.G. Holt et al. DIABETES CARE
- Adult-Onset Type 1 Diabetes: Current Understanding and Challenges
- (2021) R. David Leslie et al. DIABETES CARE
- Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes
- (2021) Dina Mansour Aly et al. NATURE GENETICS
- Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes
- (2020) Fraser W. Gibb et al. DIABETOLOGIA
- Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)
- (2020) Ernesto Maddaloni et al. Lancet Diabetes & Endocrinology
- “H” for Heterogeneity in the Algorithm for Type 2 Diabetes Management
- (2020) Pieralice Silvia et al. Current Diabetes Reports
- The Impact Of Obesity On The Increasing Incidence Of Type 1 Diabetes
- (2020) Raffaella Buzzetti et al. DIABETES OBESITY & METABOLISM
- Decline Pattern of Beta-cell Function in Adult-onset Latent Autoimmune Diabetes: an 8-year Prospective Study
- (2020) Xia Li et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High residual C-peptide likely contributes to glycemic control in type 1 diabetes
- (2020) Michael R. Rickels et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
- (2020) Julio Rosenstock et al. DIABETES CARE
- Benefit:Risk Profile of Dapagliflozin 5 mg in the DEPICT ‐1 and ‐2 Trials in Individuals with Type 1 Diabetes and BMI ≥27 kg/m 2
- (2020) Chantal Mathieu et al. DIABETES OBESITY & METABOLISM
- Adult-onset autoimmune diabetes in 2020: An update
- (2020) Ernesto Maddaloni et al. MATURITAS
- Type 1 diabetes, obesity and PCOS: Is type 1 stepping into the shoes of type 2 diabetes?
- (2020) Ethel Codner CLINICAL ENDOCRINOLOGY
- Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
- (2020) Raffaella Buzzetti et al. DIABETES
- Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
- (2020) Geremia B. Bolli et al. DIABETES CARE
- The clinical consequences of heterogeneity within and between different diabetes types
- (2020) Maria J. Redondo et al. DIABETOLOGIA
- Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
- (2020) Sara Sokooti et al. Journal of Clinical Medicine
- Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications
- (2020) Anita Jeyam et al. DIABETES CARE
- Efficacy and safety of adding sotagliflozin, a dual sodium‐glucose co‐transporter ( SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m 2
- (2020) Thomas Danne et al. DIABETES OBESITY & METABOLISM
- Impact of routine clinic measurement of serum C‐peptide in people with a clinician‐diagnosis of type 1 diabetes
- (2020) Evgenia Foteinopoulou et al. DIABETIC MEDICINE
- Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
- (2020) Giovanni Musso et al. PLOS MEDICINE
- Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide
- (2019) Charles Thivolet et al. DIABETOLOGIA
- A Plant-Based Meal Stimulates Incretin and Insulin Secretion More Than an Energy- and Macronutrient-Matched Standard Meal in Type 2 Diabetes: A Randomized Crossover Study
- (2019) Hana Kahleova et al. Nutrients
- Long‐term Risk of Cardiovascular Disease in Individuals with Latent Autoimmune Diabetes of Adults (UKPDS nnn)
- (2019) E. Maddaloni et al. DIABETES OBESITY & METABOLISM
- Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA 1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?
- (2019) S. M. Marren et al. DIABETIC MEDICINE
- Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes
- (2019) Paul M. McKeigue et al. BMC Medicine
- Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
- (2019) Anita Lynam et al. BMJ Open
- Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
- (2019) Manuela Battaglia et al. DIABETES CARE
- Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL
- (2019) Wolfgang Landgraf et al. DIABETES OBESITY & METABOLISM
- Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials
- (2019) Vanita R. Aroda et al. DIABETES OBESITY & METABOLISM
- The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening
- (2019) Laura M. Jacobsen et al. DIABETOLOGIA
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme
- (2018) Chantal Mathieu et al. DIABETES OBESITY & METABOLISM
- Frequent Monitoring of C-peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at Home
- (2018) Ruben H Willemsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM
- (2018) Sabine Zenz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact and Mechanisms
- (2018) Karen D Corbin et al. ENDOCRINE REVIEWS
- A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
- (2018) Anita L. Grubb et al. DIABETES CARE
- Addition of GLP‐1RA therapy to Insulin in C‐peptide Positive Patients With Type 1 Diabetes
- (2018) Nitesh D Kuhadiya et al. DIABETES OBESITY & METABOLISM
- Adult-onset autoimmune diabetes: current knowledge and implications for management
- (2017) Raffaella Buzzetti et al. Nature Reviews Endocrinology
- Elevations in the Fasting Serum Proinsulin–to–C-Peptide Ratio Precede the Onset of Type 1 Diabetes
- (2016) Emily K. Sims et al. DIABETES CARE
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects
- (2016) Meena Shah et al. EUROPEAN JOURNAL OF NUTRITION
- C-peptide and the pathophysiology of microvascular complications of diabetes
- (2016) J. Wahren JOURNAL OF INTERNAL MEDICINE
- Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
- (2015) Angus G. Jones et al. DIABETES CARE
- Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
- (2015) R. David Leslie et al. DIABETOLOGIA
- Reduced β-cell function in early preclinical type 1 diabetes
- (2015) Maarit K Koskinen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes
- (2015) Jin Ook Chung et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Combination immunotherapies for type 1 diabetes mellitus
- (2015) Paolo Pozzilli et al. Nature Reviews Endocrinology
- Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9
- (2015) Marta Hernandez et al. BMC Endocrine Disorders
- Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement
- (2015) Ernesto Maddaloni et al. PLoS One
- Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes
- (2014) Lingjiao Liu et al. DIABETES CARE
- Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
- (2014) Asa K. Davis et al. DIABETES CARE
- Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and Type 2 diabetes: Action LADA 8
- (2014) C. B. Juhl et al. DIABETIC MEDICINE
- High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)
- (2014) Simona Zampetti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants
- (2013) J. M. Sosenko et al. DIABETES
- Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
- (2013) J. M. Lachin et al. DIABETES
- Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study
- (2013) A. Barker et al. DIABETES OBESITY & METABOLISM
- The clinical utility of C-peptide measurement in the care of patients with diabetes
- (2013) A. G. Jones et al. DIABETIC MEDICINE
- The many faces of diabetes: a disease with increasing heterogeneity
- (2013) Tiinamaija Tuomi et al. LANCET
- Development of SI-traceable C-peptide certified reference material NMIJ CRM 6901-a using isotope-dilution mass spectrometry-based amino acid analyses
- (2012) Tomoya Kinumi et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study): A Nationwide, Multicenter, Clinic-Based Cross-Sectional Study
- (2012) Z. Zhou et al. DIABETES
- C-Peptide Levels Are Associated With Mortality and Cardiovascular Mortality in Patients Undergoing Angiography: The LURIC study
- (2012) N. Marx et al. DIABETES CARE
- Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes
- (2012) R. E. J. Besser et al. DIABETES CARE
- C-peptide response to glucagon challenge is correlated with improvement of early insulin secretion by liraglutide treatment
- (2012) Michinori Takabe et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up
- (2012) S Bo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6)
- (2012) Simona Zampetti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes
- (2012) Tadashi Iwao et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- C-Peptide: A New Mediator of Atherosclerosis in Diabetes
- (2012) Dusica Vasic et al. MEDIATORS OF INFLAMMATION
- Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients
- (2011) Bo-Yeon Kim et al. ACTA DIABETOLOGICA
- LADA prevalence estimation and insulin dependency during follow-up
- (2011) Yongsoo Park et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)
- (2011) R. C. Loopstra-Masters et al. DIABETOLOGIA
- Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
- (2011) Jonatan I. Bagger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes
- (2010) Kristine J. Hare et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Traceable Amino Acid Analyses of Proteins and Peptides by Isotope-Dilution Mass Spectrometry Using Precolumn Derivatization Reagent
- (2010) Tomoya KINUMI et al. ANALYTICAL SCIENCES
- Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)
- (2010) S. Zampetti et al. DIABETIC MEDICINE
- Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants
- (2009) J. M. Sosenko et al. DIABETES CARE
- Lise G. Heding, 1936–2008
- (2009) J. Ludvigsson DIABETOLOGIA
- Latent (slowly progressing) autoimmune diabetes in adults
- (2008) Jochen Seissler Current Diabetes Reports
- Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of -Cell Function in Therapeutic Trials in Type 1 Diabetes
- (2008) C. J. Greenbaum et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started